CLINICAL TRIAL APPROVAL FOR SIM0395 (PAXALISIB) ISSUED BY THENATIONAL MEDICAL PRODUCTS ADMINISTRATION
Thank you for the Simcere link. Yes they now have trial approval for paxalisib for the treatment of glioblastoma (GBM) covering patients of new diagnosis and relapse.
We now wait for an announcement from GCAR for details of the China GBM AGILE study arms.
Regards.
- Forums
- ASX - By Stock
- KZA
- How does GBM AGILE work?
How does GBM AGILE work?, page-59
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online